QDEL Stock Analysis: Buy, Sell, or Hold?
QDEL - QuidelOrtho Corporation Common Stock
$14.78
-0.82 (-5.26%)
▼
5d:
-3.02%
30d:
-34.89%
90d:
-48.9%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
QDEL is down 12.4% this week, but smart money is accumulating calls. Top strike: $17.5 2026-06-18 with 184 OI. Call ratio: 96% View Scanner →
Strength: 10.0/10
Get Alerted When QDEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: QDEL trading at deep discount. Market pricing in -20.2% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: QDEL trading at deep discount. Market pricing in -20.2% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$56.92
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$35.35
58.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: QDEL is currently trading at $14.78, which is considered oversold relative to its 30-day fair value range of $16.75 to $22.54. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.0) compared to its historical average (9.8). Remarkably, the market is currently pricing in an annual earnings decline of 20.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, QDEL is in a strong downtrend. The price is currently testing key support at $14.75. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: QDEL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.67 (+134.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QDEL is in a strong downtrend. The price is currently testing key support at $14.75. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: QDEL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.67 (+134.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$16.75 -
$22.54
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.3%)
- BULLISH: Trading 134.6% below Wall St target ($34.67)
Fair Price Analysis
30-Day Fair Range
$16.75 -
$22.54
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$14.75
Resistance Level
$19.72
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.96
Wall Street Target
$34.67
(+134.6%)
Revenue Growth (YoY)
2.2%
Earnings Growth (YoY)
-77.1%
Profit Margin
-41.5%
Valuation Discount vs History
-20.2% cheaper
PE vs Historical
5.0 vs 9.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-20.2%
(market-implied from PE analysis)
1-Year Target
$13.30
(-10%)
2-Year Target
$11.97
(-19%)
3-Year Target
$10.77
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→10)
$21.31
(+44%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 37.5%)
$173.69
(+1075%)
Base:
(SPY PE: 5.0, Growth: 37.5%)
$38.42
(+160%)
Bear:
(PE: 4.2, Growth: 37.5%)
$32.66
(+121%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.0 to 9.8
Stabilization Target:
$29.23
(+97.8%)
PE Expansion Potential:
+97.8%
Share & Embed Analysis
Last updated: March 30, 2026 8:56 AM ET
Data refreshes hourly during market hours. Next update: 9:56 AM
Data refreshes hourly during market hours. Next update: 9:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QDEL showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Brian J Blaser
BUY
10540 shares
2026-02-13
Joseph M Busky
BUY
3370 shares
2026-02-13
Matthew Strobeck
BUY
10000 shares
2026-02-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 56 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 53 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 58 HOLD |
Advanced QDEL Option Strategies
Professional options setups generated by AI based on today's QDEL price and gamma walls.
